615 related articles for article (PubMed ID: 31487466)
21. Technology development to evaluate the effectiveness of viscosity reducing excipients.
Banik N; Braun S; Gerit Brandenburg J; Fricker G; Kalonia DS; Rosenkranz T
Int J Pharm; 2022 Oct; 626():122204. PubMed ID: 36116691
[TBL] [Abstract][Full Text] [Related]
22. Enhancing Stability and Reducing Viscosity of a Monoclonal Antibody With Cosolutes by Weakening Protein-Protein Interactions.
Dear BJ; Hung JJ; Laber JR; Wilks LR; Sharma A; Truskett TM; Johnston KP
J Pharm Sci; 2019 Aug; 108(8):2517-2526. PubMed ID: 30885659
[TBL] [Abstract][Full Text] [Related]
23. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
[TBL] [Abstract][Full Text] [Related]
24. A Formulation Development Approach to Identify and Select Stable Ultra-High-Concentration Monoclonal Antibody Formulations With Reduced Viscosities.
Whitaker N; Xiong J; Pace SE; Kumar V; Middaugh CR; Joshi SB; Volkin DB
J Pharm Sci; 2017 Nov; 106(11):3230-3241. PubMed ID: 28668340
[TBL] [Abstract][Full Text] [Related]
25. Protein-Protein Interactions, Clustering, and Rheology for Bovine IgG up to High Concentrations Characterized by Small Angle X-Ray Scattering and Molecular Dynamics Simulations.
Chowdhury A; Guruprasad G; Chen AT; Karouta CA; Blanco MA; Truskett TM; Johnston KP
J Pharm Sci; 2020 Jan; 109(1):696-708. PubMed ID: 31726055
[TBL] [Abstract][Full Text] [Related]
26. Quantitative Correlation between Viscosity of Concentrated MAb Solutions and Particle Size Parameters Obtained from Small-Angle X-ray Scattering.
Fukuda M; Moriyama C; Yamazaki T; Imaeda Y; Koga A
Pharm Res; 2015 Dec; 32(12):3803-12. PubMed ID: 26078002
[TBL] [Abstract][Full Text] [Related]
27. Combining Scattering Experiments and Colloid Theory to Characterize Charge Effects in Concentrated Antibody Solutions.
Gulotta A; Polimeni M; Lenton S; Starr CG; Stradner A; Zaccarelli E; Schurtenberger P
Mol Pharm; 2024 May; 21(5):2250-2271. PubMed ID: 38661388
[TBL] [Abstract][Full Text] [Related]
28. Understanding the Role of Preferential Exclusion of Sugars and Polyols from Native State IgG1 Monoclonal Antibodies and its Effect on Aggregation and Reversible Self-Association.
Sudrik CM; Cloutier T; Mody N; Sathish HA; Trout BL
Pharm Res; 2019 May; 36(8):109. PubMed ID: 31127417
[TBL] [Abstract][Full Text] [Related]
29. Novel salts of dipicolinic acid as viscosity modifiers for high concentration antibody solutions.
Ke P; Batalha IL; Dobson A; Tejeda-Montes E; Ekizoglou S; Christie G; McCabe J; van der Walle CF
Int J Pharm; 2018 Sep; 548(1):682-688. PubMed ID: 30009985
[TBL] [Abstract][Full Text] [Related]
30. Weak antibody-cyclodextrin interactions determined by quartz crystal microbalance and dynamic/static light scattering.
Härtl E; Dixit N; Besheer A; Kalonia D; Winter G
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):781-9. PubMed ID: 23685354
[TBL] [Abstract][Full Text] [Related]
31. Viscosity Reduction and Stability Enhancement of Monoclonal Antibody Formulations Using Derivatives of Amino Acids.
Srivastava A; O'Dell C; Bolessa E; McLinden S; Fortin L; Deorkar N
J Pharm Sci; 2022 Oct; 111(10):2848-2856. PubMed ID: 35605688
[TBL] [Abstract][Full Text] [Related]
32. Small-scale screening method for low-viscosity antibody solutions using small-angle X-ray scattering.
Fukuda M; Watanabe A; Hayasaka A; Muraoka M; Hori Y; Yamazaki T; Imaeda Y; Koga A
Eur J Pharm Biopharm; 2017 Mar; 112():132-137. PubMed ID: 27890509
[TBL] [Abstract][Full Text] [Related]
33. Characterizing Protein-Protein Interactions and Viscosity of a Monoclonal Antibody from Low to High Concentration Using Small-Angle X-ray Scattering and Molecular Dynamics Simulations.
Chowdhury AA; Manohar N; Lanzaro A; Kimball WD; Witek MA; Woldeyes MA; Majumdar R; Qian KK; Xu S; Gillilan RE; Huang Q; Truskett TM; Johnston KP
Mol Pharm; 2023 Nov; 20(11):5563-5578. PubMed ID: 37782765
[TBL] [Abstract][Full Text] [Related]
34. Protein-Protein Interactions of Highly Concentrated Monoclonal Antibody Solutions via Static Light Scattering and Influence on the Viscosity.
Hung JJ; Dear BJ; Karouta CA; Chowdhury AA; Godfrin PD; Bollinger JA; Nieto MP; Wilks LR; Shay TY; Ramachandran K; Sharma A; Cheung JK; Truskett TM; Johnston KP
J Phys Chem B; 2019 Jan; 123(4):739-755. PubMed ID: 30614707
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 2.
Hu Y; Toth RT; Joshi SB; Esfandiary R; Middaugh CR; Volkin DB; Weis DD
J Pharm Sci; 2020 Jan; 109(1):353-363. PubMed ID: 31195015
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic Antibody Engineering To Improve Viscosity and Phase Separation Guided by Crystal Structure.
Chow CK; Allan BW; Chai Q; Atwell S; Lu J
Mol Pharm; 2016 Mar; 13(3):915-23. PubMed ID: 26849155
[TBL] [Abstract][Full Text] [Related]
37. Protein-protein interactions in dilute to concentrated solutions: α-chymotrypsinogen in acidic conditions.
Blanco MA; Perevozchikova T; Martorana V; Manno M; Roberts CJ
J Phys Chem B; 2014 Jun; 118(22):5817-31. PubMed ID: 24810917
[TBL] [Abstract][Full Text] [Related]
38. Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution.
Liu J; Nguyen MD; Andya JD; Shire SJ
J Pharm Sci; 2005 Sep; 94(9):1928-40. PubMed ID: 16052543
[TBL] [Abstract][Full Text] [Related]
39. Ultrasonic storage modulus as a novel parameter for analyzing protein-protein interactions in high protein concentration solutions: correlation with static and dynamic light scattering measurements.
Saluja A; Badkar AV; Zeng DL; Nema S; Kalonia DS
Biophys J; 2007 Jan; 92(1):234-44. PubMed ID: 17028129
[TBL] [Abstract][Full Text] [Related]
40. The effect of arginine glutamate on the stability of monoclonal antibodies in solution.
Kheddo P; Tracka M; Armer J; Dearman RJ; Uddin S; van der Walle CF; Golovanov AP
Int J Pharm; 2014 Oct; 473(1-2):126-33. PubMed ID: 24992318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
